Stevanato Group SpA(NYSE : STVN)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Medical Specialties
|TMO||Thermo Fisher Scientific, Inc.||1.67%||601.96||1.0%||$760.61m|
|ISRG||Intuitive Surgical, Inc.||-0.12%||335.90||0.8%||$381.60m|
|ALGN||Align Technology, Inc.||0.71%||598.50||6.3%||$327.56m|
|BDX||Becton, Dickinson & Co.||0.94%||245.00||1.0%||$313.44m|
|EW||Edwards Lifesciences Corp.||0.19%||115.22||0.4%||$260.10m|
|BSX||Boston Scientific Corp.||0.52%||44.36||1.0%||$257.01m|
|IDXX||IDEXX Laboratories, Inc.||1.29%||649.28||3.8%||$247.16m|
|A||Agilent Technologies, Inc.||0.87%||156.97||1.6%||$218.21m|
|BAX||Baxter International, Inc.||1.27%||80.69||1.8%||$192.25m|
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates in Biopharmaceutical and Diagnostic Solutions and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.